CID 16204654

5'-gggtgggcg-3'

Structural Information

Molecular Formula
C89H111N40O47P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=O)(OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)O)N6C=NC7=C6N=C(NC7=O)N)N8C=NC9=C8N=C(NC9=O)N)S)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O
InChI
InChI=1S/C89H111N40O47P9S9/c1-30-13-122(89(140)120-73(30)131)52-6-33(43(162-52)17-154-182(147,191)173-36-9-55(126-26-101-62-69(126)109-84(94)116-77(62)135)167-47(36)21-158-184(149,193)175-38-11-57(128-28-103-64-71(128)111-86(96)118-79(64)137)165-45(38)19-156-180(145,189)171-34-7-53(163-41(34)15-151-177(141,142)186)124-24-99-60-67(124)107-82(92)114-75(60)133)170-179(144,188)155-18-44-37(10-56(164-44)127-27-102-63-70(127)110-85(95)117-78(63)136)174-183(148,192)159-22-48-39(12-58(168-48)129-29-104-65-72(129)112-87(97)119-80(65)138)176-185(150,194)157-20-46-35(8-54(166-46)125-25-100-61-68(125)108-83(93)115-76(61)134)172-181(146,190)153-16-42-32(5-51(161-42)121-3-2-49(90)105-88(121)139)169-178(143,187)152-14-40-31(130)4-50(160-40)123-23-98-59-66(123)106-81(91)113-74(59)132/h2-3,13,23-29,31-48,50-58,130H,4-12,14-22H2,1H3,(H,143,187)(H,144,188)(H,145,189)(H,146,190)(H,147,191)(H,148,192)(H,149,193)(H,150,194)(H2,90,105,139)(H,120,131,140)(H2,141,142,186)(H3,91,106,113,132)(H3,92,107,114,133)(H3,93,108,115,134)(H3,94,109,116,135)(H3,95,110,117,136)(H3,96,111,118,137)(H3,97,112,119,138)
InChIKey
IQPLOPMKZYDDDD-UHFFFAOYSA-N
Compound name
1-[4-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-(dihydroxyphosphinothioyloxymethyl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-sulfanylphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

3058.2651 Da
Monoisotopic Mass

-7.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3059.2724 296.2
[M+Na]+ 3081.2543 299.4
[M-H]- 3057.2578 296.3
[M+NH4]+ 3076.2989 297.3
[M+K]+ 3097.2283 297.8
[M+H-H2O]+ 3041.2624 296.5
[M+HCOO]- 3103.2633 297.5
[M+CH3COO]- 3117.2790 297.8
[M+Na-2H]- 3079.2398 300.0
[M]+ 3058.2646 299.4
[M]- 3058.2656 299.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.